Abstract
Continuous subcutaneous insulin infusion (CSII) devices, commonly referred to as insulin pumps, are a growing trend in diabetes care. Insulin pumps enable patients to program basal delivery of insulin per hour, as well as deliver boluses for food intake throughout the day. Benefits include better diabetes control, increased flexibility of basal delivery, precise bolus dosing, and improved quality of life. Limitations may include cost, insurance coverage, and fear of dependence; CSII has also been associated with infusion-site reactions, diabetic ketoacidosis, and retinopathy. A variety of pumps with features such as alarms, reminders, and Bluetooth connectivity are available. Pharmacists can play an important role in providing pump education and training for patients, as well as troubleshooting and pump management.
| Original language | English (US) |
|---|---|
| Volume | 42 |
| No | 11 |
| Specialist publication | U.S. Pharmacist |
| State | Published - Nov 1 2017 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacy
- Pharmacology
- Pharmaceutical Science
Cite this
Pumping it up : New advancements in insulin delivery. / Kessinger, Haley; Knezevich, Emily; DeSimone, Edward M.; Davidian, Michael H.
In: U.S. Pharmacist, Vol. 42, No. 11, 01.11.2017.Research output: Contribution to specialist publication › Article
}
TY - GEN
T1 - Pumping it up
T2 - New advancements in insulin delivery
AU - Kessinger, Haley
AU - Knezevich, Emily
AU - DeSimone, Edward M.
AU - Davidian, Michael H.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - Continuous subcutaneous insulin infusion (CSII) devices, commonly referred to as insulin pumps, are a growing trend in diabetes care. Insulin pumps enable patients to program basal delivery of insulin per hour, as well as deliver boluses for food intake throughout the day. Benefits include better diabetes control, increased flexibility of basal delivery, precise bolus dosing, and improved quality of life. Limitations may include cost, insurance coverage, and fear of dependence; CSII has also been associated with infusion-site reactions, diabetic ketoacidosis, and retinopathy. A variety of pumps with features such as alarms, reminders, and Bluetooth connectivity are available. Pharmacists can play an important role in providing pump education and training for patients, as well as troubleshooting and pump management.
AB - Continuous subcutaneous insulin infusion (CSII) devices, commonly referred to as insulin pumps, are a growing trend in diabetes care. Insulin pumps enable patients to program basal delivery of insulin per hour, as well as deliver boluses for food intake throughout the day. Benefits include better diabetes control, increased flexibility of basal delivery, precise bolus dosing, and improved quality of life. Limitations may include cost, insurance coverage, and fear of dependence; CSII has also been associated with infusion-site reactions, diabetic ketoacidosis, and retinopathy. A variety of pumps with features such as alarms, reminders, and Bluetooth connectivity are available. Pharmacists can play an important role in providing pump education and training for patients, as well as troubleshooting and pump management.
UR - http://www.scopus.com/inward/record.url?scp=85035030506&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85035030506&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85035030506
VL - 42
JO - U.S. Pharmacist
JF - U.S. Pharmacist
SN - 0148-4818
ER -